NKTR - Nektar Therapeutics

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue307,711165,436230,784
Cost of Revenue30,54730,21534,102
Gross Profit277,164135,221196,682
Operating Expenses
Research Development268,461203,801182,787
Selling General and Administrative52,36444,27543,266
Non Recurring15,98115,98115,981
Total Operating Expenses---
Operating Income or Loss-59,642-112,855-29,371
Income from Continuing Operations
Total Other Income/Expenses Net4,5202,387-12,399
Earnings Before Interest and Taxes-55,122-110,468-41,770
Interest Expense40,95442,18038,901
Income Before Tax-96,076-152,648-80,671
Income Tax Expense616876506
Minority Interest---
Net Income From Continuing Ops-96,692-153,524-95,256
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-96,692-153,524-81,177
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-96,692-153,524-81,177